Clinical and metabolic effects of aminophosphonate therapy in children with heart rhythm disturbances
https://doi.org/10.20538/1682-0363-2017-3-176-184
Abstract
The aim of the survey is to summarize and assess a number of studies that examined the clinical and metabolic effects of aminophosphonates, particularly dimephosphon, which possess antioxidant and membrane-stabilizing effects. This paper presents a differential effect of dimephosphon on cell membrane functional activity as well as on structural features of platelet membrane as a model of smooth muscle cell in combined therapy in children with different clinical varieties of sick sinus syndrome.
About the Authors
Olga V. SenatorovaRussian Federation
PhD, Junior Researcher, Laboratory of Epidemiology and Prevention of Cardiovascular Diseases, Tyumen Cardiology Center, branch of the Tomsk National Research Medical Center of the Russian Academy of Sciences, Tyumen, Russian Federation.
Elena B. Khramova
Russian Federation
DМ, Head of the Department of Children Diseases, Tyumen State Medical University, Tyumen, Russian Federation.
Vadim A. Kuznetsov
Russian Federation
DM, Professor, Honored Scientist of the Russian Federation, Director of Tyumen Cardiology Center, branch of the Tomsk National Research Medical Center of the Russian Academy of Sciences, Tyumen, Russian Federation.
Oksana I. Sergeychik
Russian Federation
PhD, Scientific Researcher, Laboratory of Instrumental Diagnostics, Tyumen Cardiology Center, branch of the Tomsk National Research Medical Center of the Russian Academy of Sciences, Tyumen, Russian Federation.
References
1. Balykova L.A., Nazarova I.S., Tishina A.N. Lechenie aritmij serdca u detej [Treatment of cardiac arrhythmias in children] // Prakticheskaya medicina – Practical medicine. 2011; 5 (53): 30–37 (in Russian).
2. Shkolnikova M.A., Abdulatipova I.V., Adrianov A.V., Antsupova E.S., Bolsunovskiy V.A., Vasichkina E.S., Gordeev O.L., Egorov D.F., Ildarova R.A., Kalinin L.A., Kruchia T.K., Malkina E.V., Miklashevich I.M., Noskova M.V., Poliakova E.B., Senchik K.Yu., Harlap M.S. Diagnostika i lecheniye narushenij ritma i provodimosti [Diagnostics and treatment of cardiac rhythm and conduction disturbances] // SPb.: Chelovek Publ., 2012: 432 (in Russian).
3. Pediatriya: natsionalnoye rukovodstvo. V 2 t. [Pediatrics: national guidelines]. In 2 vol. // М.: GEOTAR-Меdiа Publ., 2009: 228 (in Russian).
4. Poliakova E.B., Shkolnikova M.A. Mehanizmy formirovaniya, klassifikatsiya, klinicheskoye techeniye i prognoz «idiopaticheskih» narusheniy funktsii sinusovogo uzla v detskom vozraste [Formation mechanisms, classification, the clinical course and prognosis of “idiopathic” sinus node dysfunction in children] // Vestnik aritmologii – Journal of arrhythmology. 2008. 52: 5–13 (in Russian).
5. Veltishchev Yu. E. Kletochnye membrany I patologiya detskogo vozrasta. Problemy membrannoy patologii v pediatrii. Sbornik nauchnykh trudov. [Cell membranes and child age pathology. Membrane pathology in paediatrics. Studies collection] // M., 1984: 180 (in Russian).
6. Vladimirov Yu. A., Dobretsov G. E. Fluorestsentnye zondy v issledovanii biologicheskikh membrane [Fluorescent probes in the study of cell membranes] // М.: Nauka Publ., 1980: 320 (in Russian).
7. Sobakar M.S., Shix E.V. Antioksidantnaya terapiya i metabolicheskie podxody k lecheniyu zabolevanij serdechnososudistoj sistemy [Cardiological biopharmaceuticals in the conception of drug targeting delivery: practical results and research perspectives] // Biomedicina – Biomedicine. 2010; 1 (3): 10–21 (in Russian).
8. Maksimenko A.V. Kardiologicheskiye biopharmatsevtiki v kontseptsii napravlennogo transporta lekarstv: prakticheskiye rezultaty i issledovatelskiye perspektivy [Cardiac biopharmaceuticals in the concept of targeted transport of drugs: practical results and research prospects] // Acta naturae – Acta Naturae. 2012; 4 (3): 76–86 (in Russian).
9. Shilov A., Abdullaeva A. Antioksidanty v programme lecheniya polimorbidnyh bolnyh s metabolicheskim sindromom [Antioxydants in treatment of multimorbid patients with metabolic syndrome] // Vrach – Doctor. 2012; 7: 49–52 (in Russian).
10. Galenko-Yaroshevskiy P.A., Gukasov V.M., Gatsura V.V. Antioksidanty v sisteme sovremennoy terapii serdechnososudistoj patologii [Antioxidants in the modern treatment of cardiovascular disease] // Medicina i vysokiye tehnologii – Journal Medicine and Нigh Technology. 2014; 1: 6–20 (in Russian).
11. Philina E.A., Dlin V.V. Lekarstvennye sredstva, primenyaemye v denskoy kardiologii. In book: Tsaregorodtsev A.D., Tabolin V.A. Rukovodstvo po farmakoterapii v pediatrii I detskoi hirurgii. Т. 5. Klinicheskaya kardiologiya [Pharmakotherapy in paediatrics and paediatric surgery. Vol. 5. Clinical cardiology]. M.: Medpractikа-M Publ., 2004: 396 (in Russian).
12. Sorogin V.P., Senatorova O.V., Lykasov A.G., Zhuravleva T.D. Vliyanie aminophosphonatov na strukturu i funkciyu trombocitov u detey s disfunkciey sinusovogo uzla [Influence of aminophosphonates on platelet structure and function in children with sinus node dysfunction] // Medicinskaya nauka i obrazovaniye Urala – Ural Education and Medical Science. 2011; 1: 152–154 (in Russian).
13. Senatorova O.V., Khramova E.B., Sorogin V.P., Lykasov A.G., Rychkov A.Yu. Kliniko-patogeneticheskiye osobennosti disfunkcii sinusovogo uzla u detey pri razlichnyh klinicheskih variantah [Clinical and pathogenic peculiar features of different clinical types of sinus node dysfunction in pediatric patients] // Vestnik aritmologii – Journal of Arrhythmology. 2013; 73: 25–29 (in Russian).
14. Bulatov V.P. Primenenie dimephosphona v pediatrii [Using Dimephosphon drug in pediatric] // Poliklinika – Polyclinic. 2009; 1: 129–131 (in Russian).
15. Yurieva E.A., Semiachkina S.V., Alieva D.M., Alekseeva N.V., Yatskevich E.E., Makkaev H.M., Dlin V.V. Dimephosphon – preparat shirokogo spectra deystviya pri lechenii zabolevaniy u detey [Dimephosphon as a broad-spectrum agent for treatment diseases in children] // Vestnik pediatricheskoy farmakologii i nutritsiologii – Bulletin of Pediatric Pharmacology and Nutriciology. 2006: 3 (1): 69–76 (in Russian).
16. Dimephosphon. Registr lekarstvennyh sredstv Rossii. (Elektronny resurs) [Dimephosphon. Register of pharmaceuticals in Russia] // Rezhim dostupa: http://www. rlsnet.ru/tn_index_id_4441.htm (Data obrashcheniya) 12.12.2016]. (Electronic source). Access mode: http://www.rlsnet.ru/tn_index_id_4441.htm (Accessed date 12.12.2016) (in Russian).
17. Dlin V.V., Ignatova M.S., Osmanov I.M., Yurieva E.A., Morozov S.L. Dismetabolicheskie nefropatii u detei [Dysmetabolic nephropathy in children] // Rossiiskiy vestnik perinatologii I pediatrii – Russian Newspaper of Perinatology and Paediatrics. 2012; 5: 36–44 (in Russian).
18. Hafizyanova R.H., Merzahmedova M.K., Burykin I.M. Perspektivy primeneniya otechestvennogo preparata dimefosfon (dimetiloksobutilfosfonildimetilat) dlya lecheniya zhenschin s klimaktericheskim sindromom umerennoy stepeni tiazhesti [Dimephosphon (dimethyloxobuthylphosphonilmethylate) is promising drug for treatment of women with moderate climacteric syndrome] // Fundamentalniye issledovaniya – Fundamental Research. 2015; 1: 1955–1961 (in Russian).
19. Danilov V.I. DIMEPHOSPHON. Primeneniye v neyrohirurgii i nevrologii [DIMEPHOSPHON. Using in neurology & neurosurgery] // Poliklinika – Polyclinic. 2008; 2: 12–13 (in Russian).
20. Kuznetsov M.R., Virgansky A.O., Kosykh I.V., Yumin S.M., Kunitsyn N.V., Golosnitskiy P.Yu., Neshodimov L.A., Magnitskiy L.A., Mnatsakanyan G.T., Fukalov A.S. Vozmozhnosti metabolicheskoy terapii pri ateroskleroze [The possibility of metabolic treatment in atherosclerosis] // Nevrologicheskiy zhurnal – Neurology Journal. 2014; 4: 56–60. DOI:10.18821/1560-9545-2014-19-4-56-60 (in Russian).
21. Poluektov M.G., Tsenteradze S.L. Vozmozhnosti lecheniya ishemicheskogo insulta v nevrologicheskom statsionare [Ischemic Stroke Treatment in Neurological Unit] // Effektivnaya farmakoterapiya – Effective Pharmacotherapy. 2014; 49: 32–38 (in Russian).
22. Frolova N.Yu., Buryakina A.V., Melnikova T.I. Neyroprotektory v pediatricheskoy praktike [Neuroprotectors in pediatric practice] // Remedium – Remedium. 2015; September: 54–60. DOI:10.21518/1561-5936-2015-9-54-60 (in Russian).
23. Tsaregorodtsev A.D., Nikolaev A.M. Terapevticheskaya effektivnost dimephosphona u detey rannego vozrasta [Therapeutic effect of dimephosphon in early-aged children] // Rossiyskiy Vestnik Perinatologii i Pediatrii – Russian Bulletin of Perinatology and Pediatrics. 1994; 39 (6): 34–36 (in Russian).
24. Vizel A.A., Vizel A.O., Shchukina L.I. Dimetiloksobutilphosphonildimetilat (Dimephosphon): primeneniye v pulmonologii i phtiziatrii [Dimethyloxobutylphosphonyldimethylat (Dimephosphon): using in pulmonology and phthisiology] // Pulmonologija i allergologija - Pulmonology and Allergology. 2013; 3: 41–44 (in Russian).
25. Vizel A.O., Garaev R.S. Novyi aspekt farmakologicheskogo podkhoda k soedineniyam fosfora.: dimefosfon [A new aspect of pharmacological approach to phosphorus compounds: dimephosphone] / Kazan: Pechat–Servis–XXI vek Publ., 2011: 189 (in Russian).
26. Bershova T.V., Gasanov A.G., Monaenkova S.V., Bakanov M.I., Basargina E.N., Ivanov A.P. Vozmozhnye mechanism i patofisiologicheskaya znachimost apoptosa v patogeneze chronicheskoy serdechnoy nedostatochnosti u detei i podrostkov [Possible mechanisms and pathophysiologic value of apoptosis in pathogenesis of congestive heart failure in children and teenagers] // Pediatriya – Paediatrics. 2010; 89 (3): 21–27 (in Russian).
27. Xiao J., She Q., Wang Y. et al. Effect of allopurinol on cardiomyocyte apoptosis in rats after myocardial infarction // Eur. J. of Heart Failure. 2009; 11 (1): 20–27. DOI: 10.1093/eurjhf/hfn003.
28. Orlova E.V., Kostanyan I.A., Panov V.P. Rol regulyatornykh belkov apoptoza v kletochnom Са2+ gomeostaze [Regulatory proteins of apoptosis in the cell Са2+ homeostasis] // Khimiko-farmatsevticheskiy zhurnal – Chemistry and pharmaceutical journal. 2005; 12: 3–8 (in Russian).
29. Ershova A.K. O primenenii preparata Xidiphon pri narushenii kaltsievogo obmena [About the use of xydiphone in calcium metabolism disorders] // Russkiy medicinskiy zhurnal - Russian Мedical Journal. 2010; 18 (14): 884–886 (in Russian).
30. Djokanovic N., Klieger-Grossmann C., Koren G. Does treatment with bisphosphonates endanger the human pregnancy? // J Obstet Gynaecol Can. 2008; 30 (12): 1146–1148.
31. Russell RG. Bisphosphonates: mode of action and pharmacology // Pediatrics. 2007; 119: 150–162.
32. Dwan K., Phillipi C.A., Steiner R.D., Basel D. Bisphosphonate therapy for osteogenesis imperfecta // Cochrane Database Syst. Rev. 2016; 19.
33. Osipova L.A., Shelehova T.V., Bogoslovskaya S.I., Nikiforova N.E. Optimizatsiya farmakoterapii osteopenii u detey s hronicheskim pielonefritom [Оptimization of pharmacotherapy of osteopenia in children with chronic pyelonephritis] // Saratovskiy nauchno-meditsinskiy zhurnal – Saratov Journal of Medical Scientific Research. 2010; 6 (1): 43–45 (in Russian).
34. Maltsev S.V., Mansurova G. S. Sovremennye aspekty osteоporoza u detey [Modern aspects of osteoporosis in children] // Prakticheskaya meditsina – Practical medicine. 2015; 92 (7): 15–21 (in Russian).
35. Dae Hyun Kim, James R. Rogers, Lisa A. Fulchino, Caroline A. Kim, Daniel H. Solomon, Seoyoung C. Kim. Bisphosphonates and Risk of Cardiovascular. Events: A Meta-Analysis // PLoS One. 2015; Apr 17; 10 (4). DOI:10.1371/journal.pone.0122646.
36. Balykova L.A., Balashov V.P., Shkolnikova M.A., Kemaeva N.N. Effektivnost dimefosfona pri narusheniyakh ritma sertsa u detey [Elektronnyi resurs] (Efficiency of dimiphosphon in children’s heart rhythm disturbance [Electronic resource]. Rezhym dostupa: http://nature.web.ru/db/msg.html?mid=1174291&s=111400060 [Data obrashcheniya 06.03.2017] - Access mode: http://nature.web.ru/db/msg.html?mid=1174291&s=111400060 [Application date 06.03.2017].
37. Balykova L.A., Balashov V.P., Markelova I.A., Almyasheva M.I. Preparaty metabolicheskogo tipa deystviya v lechenii aritmiy serdtsa [Metabolic agents in therapy of cardiac arrhythmias]. Saransk: Referent Publ., 2007: 134 (in Russian).
38. Senatorova O.V., Khramova E.B. Mekhanizm formirovaniya disfunkcii sinusovogo uzla u detey [The mechanisms of formation of sinus node dysfunction in children] // Lechenie i profilaktika – Treatment and Рrevention. 2016; 1: 35–38 (in Russian).
39. Svatko L.G., Tsibulkina V.N., Studentsova I.A., Rafailov V.V. Diagnosticheskie kriterii i ocenka effektivnosti primeneniya dimephosphona v lechenii sekretornogo srednego otita u detey [Diagnostic criteria and effectiveness evaluation of dimephosphon in treatment of secretory otitis media in children]. Aktualniye problemy otorinolaringologii. Sbornik trudov [Actual problems of otorhinolaryngology. Collection of scientific works]. М., 1997: 136 (in Russian).
40. Hafizyanova R.H., Borodin Ju.I. Farmakoterapiya hronicheskoy placentarnoy nedostatochnosti [Pharmacotherapy of chronic placental insufficiency] // Kazanskiy medicinskiy zhurnal – Kazan Medical Journal. 2003; 6: 443–446 (in Russian).
Review
For citations:
Senatorova O.V., Khramova E.B., Kuznetsov V.A., Sergeychik O.I. Clinical and metabolic effects of aminophosphonate therapy in children with heart rhythm disturbances. Bulletin of Siberian Medicine. 2017;16(3):176-184. (In Russ.) https://doi.org/10.20538/1682-0363-2017-3-176-184